Cargando…
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
Cancer is one of the leading causes of death worldwide, and conventional cancer therapies such as surgery, chemotherapy, and radiotherapy do not address the underlying molecular pathologies, leading to inadequate treatment and tumor recurrence. Angiogenic factors, such as EGF, PDGF, bFGF, TGF-β, TGF...
Autores principales: | Le, Bao T., Raguraman, Prithi, Kosbar, Tamer R., Fletcher, Susan, Wilton, Steve D., Veedu, Rakesh N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307321/ https://www.ncbi.nlm.nih.gov/pubmed/30594893 http://dx.doi.org/10.1016/j.omtn.2018.11.007 |
Ejemplares similares
-
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021) -
Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide
Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
por: Le, Bao T., et al.
Publicado: (2020) -
Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2019) -
Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2020) -
Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro
por: Raguraman, Prithi, et al.
Publicado: (2020)